NanoBio Gets Anthrax Decontamination Contract - News Item

NanoBio® Corporation announced today that it has been awarded a $70,000, six-month contract from the U. S. Environmental Protection Agency (EPA).  This Phase I award is from the EPA's Small Business Innovation Research Program (SBIR) and will be used to optimize NanoBio's environmental decontamination product, NanoProtect™.  The SBIR program provides for an additional $225,000 that could be awarded to NanoBio based on results from these Phase I studies.

NanoProtect's development plan will result in a safe bio-decontaminant that kills bacteria, viruses, spores and fungi while being uniquely non-toxic to humans or the environment.  The EPA's specific interest relates to their Safe Buildings Program where NanoProtect would be used by first responders in the event of a bio-attack or biohazard accident to decontaminate facilities and equipment.  In addition to an excellent safety profile, it is expected that deployment costs will be significantly lower with NanoProtect as compared to currently available technologies.

John Coffey, NanoBio's Vice President, Business Development states, “The award of this contract identifies the unique role NanoBio's technology could play in the EPA's Safe Buildings Program.  It provides an important focus for the development of this product and facilitates the introduction of NanoProtect to other government agencies to include the Department of Homeland Security.”

Posted 2nd March 2004

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.